Impact of physicians' awareness of prostate-specific antigen doubling time (PSADT) on treatment (Tx) decisions in high-risk (HR) biochemically recurrent (BCR) prostate cancer (PC).
| Published in: | Journal of Clinical Oncology Vol. 43; pp. 354 - 479 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
American Society of Clinical Oncology
2/10/2025 Supplement5
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184084584&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184084584 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2/10/2025 Supplement5 vid: 43 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 184084584 10.1200/JCO.2025.43.5_suppl.354 184084584 ppf: 354 ppct: 125 formats: tig: atl: Impact of physicians' awareness of prostate-specific antigen doubling time (PSADT) on treatment (Tx) decisions in high-risk (HR) biochemically recurrent (BCR) prostate cancer (PC). aug: au: Morgans, Alicia K. Touya, Maelys El-Chaar, Nader N. Elsouda, Dina Ramaswamy, Krishnan Adejumo, Kelechi L. Gentile, Danielle Feinberg, Bruce A. Asgarisabet, Parisa Pathak, Prathamesh Freedland, Stephen J. affil: Dana-Farber Cancer Institute, Boston, MA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|